Regulation of platform economy to focus on anti-trust, data security, and personal information protection; U.S. might ban import of rare earth metals from China for military use; new process to expedite application of certain trademarks
Aggie Liu, Binxin Li, Yun Chen and Muzi Xuan of FenXun Partners, highlight China's 2021 legislative and enforcement developments in the intellectual property sector including how they respond to challenges posed by emerging technologies and stimulate innovative vitality, significant cases that strengthen IP protection mechanisms and standards, and what the future holds for IP in 2022
Groundbreaking algorithm recommendation regulation finalized; CSRC pilots market makers for STAR Market; and copyright administration prohibits digital music exclusive copyright arrangements
Ting Wu of Haiwen & Partners reviews the regulatory reforms taking place in China's life science and healthcare sector including legislation that has been released to encourage innovation and broaden market access to drugs, implementation of the patent linkage system, increasing antitrust enforcement pressure in the pharma sector, regulating medical devices, cosmetics and online hospitals.
Senior legal counsel discusses how IP rights must be proactively and creatively defended. China's strict scrutiny of its jewelry industry may further tighten, with specific AML rules expected to arrive in the near future.
Beijing Municipality opens up IP-related arbitration to foreign institutions
Hong Kong Court grants landmark interlocutory injunctions in IP Case; Draft amendment to Anti-Monopoly Law targets platform economy; 4 G-SIBs to comply with new TLAC requirements By 2025
Criteria for determining willful infringement of intellectual property are specified
CNIPA differentiates patent and advertising violations
Rules for registration of patent pledges are revised
